Peptron`s PT105 established the bioequivalence with Takeda`s Leuplin
28 Nov 2022 //
PRNEWSWIRE
Qilu Pharmaceutical and Peptron Sign License Agreement for anti-MUC1 ADC
16 Apr 2021 //
PRNEWSWIRE
Repurposing a diabetes drug to slow Parkinson’s
23 Jul 2018 //
FIERCE BIOTECH
New SR Exendin-4 Formulation proves effective against Parkinson`s
16 Jul 2018 //
BIOSPECTRUM
Peptron Expands Exclusive License with NIH to Support Developing SR-exenatide
23 Apr 2018 //
PR NEWSWIRE